Three Canadians living with vasculitis, a rare life-threatening disease, are speaking up about the inequities in care and treatment access, and why advocacy is more important than ever.
In 2016, Bob Acton lost his short, courageous battle against amyotrophic lateral sclerosis, or ALS. Now, eight years later, those closest to him continue to grapple with the immeasurable void created by his passing.